AIM ImmunoTech AIM Slides 26 to 024 as Bearish Pressure Persists Bold Eagle Acquisition Corp Right BEAGR Drops 25 to 021 Nearing Critical Support Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29 Ibotta Inc IBTA Edges Higher as Shares Test Resistance Zone